The Chinese Medicine Sector Investment Value Of Listed Companies Research

Chinese capital market is the transition from emerging markets to mature markets. For along time, The majority of investors in securities market investment philosophy is not perfect,not sound. Capital market’s prices don’t reflect the true value completely. The valueinvestment idea is being marginalized. However, speculation is leading the price trend. IfChinese securities market becomes mature, it will need continuous reform and developmentto develop mature securities market direction. This study is based on the plate of the valuationof listed companies of Chinese medicine research, value investors provide reference basis.ITcan achieve the purpose of achieve the desired optimal portfolio.The content of this paper is about the research of background, the research of purposeand significance, and the research of methods and content are discussed. By analyzinginvestment value of listed company of the theoretical basis and methods, a detailedintroduction to securities investment value analysis method and the valuation method havebeen introduced. We elaborate the analysis method of stock investment value and valuationmethods and choose the price-earnings ratio and PEG index as the research method andintroduce the meaning and calculation method of the price-earnings ratio and PEG valuationmethod. Then, it’s about total analysis of traditional Chinese medicine plate, in these chapters,firstly we analysis present situation and investment prospect of traditional Chinese medicineplate, then introduce simply traditional Chinese medicine plate listing Corporation financialsituation. In the process of analysis, The paper will be focused on resource monopoly,intellectual property and brand value of Chinese medicine plate value and the historical trendof Chinese medicine plate resources characteristic analysis and financial statement ofanalysis.In this paper, Yunnan Baiyao (000538), Tang (600085), Donga A (000423) and Pien TzeHuang (600436) four listing Corporation as the main object of study. Firstly, it statesfundamentals and the influence of four factors, and analysis market trend. Secondly, it willanalysis the resource status of four listing Corporation product features and sales strategy.Finally, from a financial point of view of profitability, analysis operating capacity, solvencyand growth in four aspects analysis financial position of the listing Corporation. Then, it states investment risk of traditional Chinese medicine plate listing Corporation from the systematicrisk and unsystematic risk. In the Chinese medicine sector, the stock investment of listedcompanies should pay attention to the risk analysis. Two aspects of systematic risk andunsystematic risk is analyzed. Finally,summed up Chinese medicine sector listed companystock investment strategy, simply summarized the this article main research conclusion andsome problems which need to be studied further.